INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 213 filers reported holding INSMED INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $565,600 | +1.9% | 22,400 | -14.8% | 0.00% | 0.0% |
| Q2 2023 | $554,930 | +23.8% | 26,300 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $448,415 | -14.7% | 26,300 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $525,474 | -37.4% | 26,300 | -32.6% | 0.00% | -50.0% |
| Q3 2022 | $840,000 | -86.1% | 39,000 | -87.2% | 0.00% | -66.7% |
| Q2 2022 | $6,027,000 | +66.8% | 305,635 | +98.8% | 0.01% | +100.0% |
| Q1 2022 | $3,614,000 | +21.7% | 153,776 | +41.2% | 0.00% | +50.0% |
| Q4 2021 | $2,969,000 | +6.7% | 108,935 | +7.8% | 0.00% | 0.0% |
| Q3 2021 | $2,783,000 | +204.5% | 101,080 | +214.5% | 0.00% | +100.0% |
| Q2 2021 | $914,000 | +18.2% | 32,140 | +41.6% | 0.00% | 0.0% |
| Q1 2021 | $773,000 | +2.4% | 22,695 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $755,000 | +3.4% | 22,695 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $730,000 | -13.6% | 22,695 | -26.0% | 0.00% | 0.0% |
| Q2 2020 | $845,000 | +1.4% | 30,678 | -40.9% | 0.00% | 0.0% |
| Q1 2020 | $833,000 | -41.4% | 51,929 | -12.7% | 0.00% | 0.0% |
| Q4 2019 | $1,421,000 | -55.1% | 59,513 | -66.6% | 0.00% | -66.7% |
| Q3 2019 | $3,168,000 | -41.0% | 178,045 | -15.1% | 0.00% | -40.0% |
| Q2 2019 | $5,366,000 | -31.4% | 209,640 | -22.0% | 0.01% | -37.5% |
| Q1 2019 | $7,817,000 | +317.6% | 268,919 | +88.2% | 0.01% | +300.0% |
| Q4 2018 | $1,872,000 | -49.0% | 142,918 | -21.2% | 0.00% | -33.3% |
| Q3 2018 | $3,667,000 | +97.0% | 181,395 | +130.6% | 0.00% | +50.0% |
| Q2 2018 | $1,861,000 | +34.7% | 78,650 | +5.7% | 0.00% | 0.0% |
| Q3 2015 | $1,382,000 | -22.5% | 74,426 | +1.9% | 0.00% | 0.0% |
| Q2 2015 | $1,784,000 | +17.3% | 73,037 | -0.1% | 0.00% | 0.0% |
| Q1 2015 | $1,521,000 | +13.0% | 73,115 | -16.0% | 0.00% | +100.0% |
| Q4 2014 | $1,346,000 | +17.7% | 86,997 | -0.8% | 0.00% | 0.0% |
| Q3 2014 | $1,144,000 | -37.8% | 87,685 | -4.7% | 0.00% | -50.0% |
| Q2 2014 | $1,839,000 | +14.7% | 92,044 | +9.3% | 0.00% | 0.0% |
| Q1 2014 | $1,603,000 | +5.5% | 84,205 | -5.7% | 0.00% | 0.0% |
| Q4 2013 | $1,519,000 | +3.0% | 89,314 | -5.5% | 0.00% | 0.0% |
| Q3 2013 | $1,475,000 | – | 94,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |